This inventor holds 4 USPTO granted patents. Top assignee: Sandoz Gmbh. Active years: 1991-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1996
Title: Assunta Imperato: Innovator in Medicinal Chemistry
Introduction
Assunta Imperato is a notable inventor based in Rome, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments aimed at reducing dependency on certain agents. With a total of 4 patents to her name, her work has garnered attention in the pharmaceutical industry.
Latest Patents
Among her latest patents, Assunta has focused on the use of 5HT-3 antagonists in preventing or reducing dependency on dependence-inducing agents. This invention provides a method for utilizing a 5HT-3 antagonist in the manufacture of a medicament suitable for the prevention or reduction of such dependencies. Her innovative approach has the potential to impact the treatment landscape significantly.
Career Highlights
Assunta currently works at Sandoz GmbH, a leading global healthcare company. Her role involves research and development in the field of pharmacology, where she applies her expertise to create effective medicinal solutions. Her dedication to advancing medical science is evident in her ongoing projects and research initiatives.
Collaborations
Assunta collaborates with Dietmar Romer, a fellow researcher in her field. Together, they work on various projects that aim to enhance the efficacy of medicinal treatments and explore new therapeutic avenues.
Conclusion
Assunta Imperato's contributions to medicinal chemistry and her innovative patents highlight her role as a key figure in the pharmaceutical industry. Her work continues to pave the way for advancements in treatment options for dependency-related issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
